Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
pharmaceutical market for GLP-1 receptor agonists (RAs) indicated for Type 2 diabetes and chronic weight management
[PMID: 23089304] PubMed record related to this compound for laboratory literature review
The markedly reduced risk here for alcohol use disorder patients taking GLP-1 agonists suggests that this class of drugs might actually be more effective than the current crop of officially approved medications for treating alcohol addiction
Other data may be used to analyze your user activity
Wei, W., Zhao, H., Wang, A., Sui, M., Liang, K., Deng, H., Ma, Y., Zhang, Y., Zhang, H., and Guan, Y
US$ 20.35
US$ 23.57
US$ 25.30
US$ 27.67
US$ 28.25
US$ 25.06
US$ 23.13
US$ 21.52
